Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
LAVAL, Que. – Valeant Pharmacueticals Inc. is buying Bausch + Lomb Holdings for US$8.7 billion in cash. The Montreal-area company will finance the deal by issuing up to $2 million of new equity, with the remainder paid for with debt.
More coming
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.